Agarwal Float (AGARWALFT)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 17.64% indicates decent demand traction.
• ROCE of 17.60% suggests reasonable returns on capital employed.
• Promoter holding of 57.55% aligns management interests with minority shareholders.
• P/E of 8.51 is low, and PEG of 0.48 hints at potential value if earnings recover.

Concerns

• Profit growth is -28.57%, with latest quarterly net profit of ₹1 Cr on ₹38 Cr sales, implying a very thin margin.
• Piotroski F-Score of 4/9 points to weak overall financial health.
• Book value, debt/equity, and ROE are not available, making balance-sheet risk impossible to assess.
• No dividend and a sharp fall from the 52-week high of ₹71.25 to ₹37.50 reduce the margin of safety.

AI Analysis

Agarwal Float trades at ₹37.50 with a market cap of just ₹21 crore. At 8.51 times earnings it looks statistically cheap, but I've learned that cheapness in a cyclical industrial business often reflects falling earnings, not opportunity. Sales grew 17.64%, yet profit declined 28.57%. The latest quarter shows ₹38 crore of sales and only ₹1 crore of net profit—roughly a 2.6% margin. That is thin. ROCE of 17.60% suggests decent capital allocation, but with no book value, no debt/equity ratio, and no ROE disclosed, I cannot assess the balance sheet. In Graham's language, I need facts; insufficient data is not a luxury I accept in a long-term investment. The Piotroski F-score of 4/9 reinforces my caution. The promoter holding of 57.55% is reassuring—skin in the game matters—but it doesn't replace a healthy financial statement. The 52-week range of ₹21.85 to ₹71.25 shows how volatile this glass producer is. The stock has fallen sharply from its high, and no dividend means I'm not being paid to wait. A PEG ratio of 0.48 looks alluring, but with reported profit falling, I don't trust it. Glass is a capital-intensive, cyclical, commodity-like business. Pricing power is limited. This could be a turnaround if management is cutting costs and if demand is recovering, but I need evidence in consecutive quarter numbers. Until profits stabilize and debt is visible, I will treat this as a cyclical watchlist candidate, not a core holding. Price is what you pay; value is what you get. Right now, I cannot fully see the value.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer